Utilization of pathway signatures to reveal distinct types of B lymphoma in the Eμ-myc model and human diffuse large B-cell lymphoma

Seiichi Mori, Rachel E. Rempel, Jeffrey T. Chang, Guang Yao, Anand S. Lagoo, Anil Potti, Andrea Bild, Joseph R. Nevins

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

The Eμ-myc transgenic mouse has provided a valuable model for the study of B-cell lymphoma. Making use of gene expression analysis and, in particular, expression signatures of cell signaling pathway activation, we now show that several forms of B lymphoma can be identified in the Eμ-myc mice associated with time of tumor onset. Furthermore, one form of Eμ-myc tumor with pre-B character is shown to resemble human Burkitt lymphoma, whereas others exhibit more differentiated B-cell characteristics and show similarity with human diffuse large B-cell lymphoma in the pattern of gene expression, as well as oncogenic pathway activation. Importantly, we show that signatures of oncogenic pathway activity provide further dissection of the spectrum of diffuse large B-cell lymphoma, identifying a subset of patients who have very poor prognosis and could benefit from more aggressive or novel therapeutic strategies. Taken together, these studies provide insight into the complexity of the oncogenic process and a novel strategy for dissecting the heterogeneity of B lymphoma.

Original languageEnglish (US)
Pages (from-to)8525-8534
Number of pages10
JournalCancer Research
Volume68
Issue number20
DOIs
StatePublished - Oct 15 2008
Externally publishedYes

Fingerprint

Lymphoma, Large B-Cell, Diffuse
Lymphoma
Gene Expression
Burkitt Lymphoma
B-Cell Lymphoma
Transgenic Mice
Dissection
Neoplasms
B-Lymphocytes
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Utilization of pathway signatures to reveal distinct types of B lymphoma in the Eμ-myc model and human diffuse large B-cell lymphoma. / Mori, Seiichi; Rempel, Rachel E.; Chang, Jeffrey T.; Yao, Guang; Lagoo, Anand S.; Potti, Anil; Bild, Andrea; Nevins, Joseph R.

In: Cancer Research, Vol. 68, No. 20, 15.10.2008, p. 8525-8534.

Research output: Contribution to journalArticle

Mori, Seiichi ; Rempel, Rachel E. ; Chang, Jeffrey T. ; Yao, Guang ; Lagoo, Anand S. ; Potti, Anil ; Bild, Andrea ; Nevins, Joseph R. / Utilization of pathway signatures to reveal distinct types of B lymphoma in the Eμ-myc model and human diffuse large B-cell lymphoma. In: Cancer Research. 2008 ; Vol. 68, No. 20. pp. 8525-8534.
@article{2ccda89d53fc42c89cf240ac453f6cf5,
title = "Utilization of pathway signatures to reveal distinct types of B lymphoma in the Eμ-myc model and human diffuse large B-cell lymphoma",
abstract = "The Eμ-myc transgenic mouse has provided a valuable model for the study of B-cell lymphoma. Making use of gene expression analysis and, in particular, expression signatures of cell signaling pathway activation, we now show that several forms of B lymphoma can be identified in the Eμ-myc mice associated with time of tumor onset. Furthermore, one form of Eμ-myc tumor with pre-B character is shown to resemble human Burkitt lymphoma, whereas others exhibit more differentiated B-cell characteristics and show similarity with human diffuse large B-cell lymphoma in the pattern of gene expression, as well as oncogenic pathway activation. Importantly, we show that signatures of oncogenic pathway activity provide further dissection of the spectrum of diffuse large B-cell lymphoma, identifying a subset of patients who have very poor prognosis and could benefit from more aggressive or novel therapeutic strategies. Taken together, these studies provide insight into the complexity of the oncogenic process and a novel strategy for dissecting the heterogeneity of B lymphoma.",
author = "Seiichi Mori and Rempel, {Rachel E.} and Chang, {Jeffrey T.} and Guang Yao and Lagoo, {Anand S.} and Anil Potti and Andrea Bild and Nevins, {Joseph R.}",
year = "2008",
month = "10",
day = "15",
doi = "10.1158/0008-5472.CAN-08-1329",
language = "English (US)",
volume = "68",
pages = "8525--8534",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "20",

}

TY - JOUR

T1 - Utilization of pathway signatures to reveal distinct types of B lymphoma in the Eμ-myc model and human diffuse large B-cell lymphoma

AU - Mori, Seiichi

AU - Rempel, Rachel E.

AU - Chang, Jeffrey T.

AU - Yao, Guang

AU - Lagoo, Anand S.

AU - Potti, Anil

AU - Bild, Andrea

AU - Nevins, Joseph R.

PY - 2008/10/15

Y1 - 2008/10/15

N2 - The Eμ-myc transgenic mouse has provided a valuable model for the study of B-cell lymphoma. Making use of gene expression analysis and, in particular, expression signatures of cell signaling pathway activation, we now show that several forms of B lymphoma can be identified in the Eμ-myc mice associated with time of tumor onset. Furthermore, one form of Eμ-myc tumor with pre-B character is shown to resemble human Burkitt lymphoma, whereas others exhibit more differentiated B-cell characteristics and show similarity with human diffuse large B-cell lymphoma in the pattern of gene expression, as well as oncogenic pathway activation. Importantly, we show that signatures of oncogenic pathway activity provide further dissection of the spectrum of diffuse large B-cell lymphoma, identifying a subset of patients who have very poor prognosis and could benefit from more aggressive or novel therapeutic strategies. Taken together, these studies provide insight into the complexity of the oncogenic process and a novel strategy for dissecting the heterogeneity of B lymphoma.

AB - The Eμ-myc transgenic mouse has provided a valuable model for the study of B-cell lymphoma. Making use of gene expression analysis and, in particular, expression signatures of cell signaling pathway activation, we now show that several forms of B lymphoma can be identified in the Eμ-myc mice associated with time of tumor onset. Furthermore, one form of Eμ-myc tumor with pre-B character is shown to resemble human Burkitt lymphoma, whereas others exhibit more differentiated B-cell characteristics and show similarity with human diffuse large B-cell lymphoma in the pattern of gene expression, as well as oncogenic pathway activation. Importantly, we show that signatures of oncogenic pathway activity provide further dissection of the spectrum of diffuse large B-cell lymphoma, identifying a subset of patients who have very poor prognosis and could benefit from more aggressive or novel therapeutic strategies. Taken together, these studies provide insight into the complexity of the oncogenic process and a novel strategy for dissecting the heterogeneity of B lymphoma.

UR - http://www.scopus.com/inward/record.url?scp=54249112852&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54249112852&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-08-1329

DO - 10.1158/0008-5472.CAN-08-1329

M3 - Article

C2 - 18922927

AN - SCOPUS:54249112852

VL - 68

SP - 8525

EP - 8534

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 20

ER -